Self-replicating intradermal RNA vaccine against SARS-CoV-2

In a recent study posted to the bioRxiv* preprint server, researchers assessed the efficiency of a controllable self-replicating ribonucleic acid (c-srRNA) vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Related Keywords

, Coronavirus Disease Covid 19 , Na , Cars , Ars Cov 2 , Vaccine , Antibodies , D4 , Coronavirus , Gene , Genes , Maging , Immunity , Immunization , N Vivo , Luciferase , Nucleotides , Pandemic , Olymerase , Protein , Espiratory , Ibonucleic Acid , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Skin , Yndrome ,